Can I prescribe mirtazapine for 1 week for appetite stimulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine for Short-Term Appetite Stimulation

Mirtazapine should NOT be prescribed for a 1-week course solely for appetite stimulation, as this practice is not supported by high-quality evidence and carries risks that outweigh potential benefits. 1

Evidence Against Short-Term Use for Appetite Stimulation

The 2024 ESPEN guidelines on nutrition in dementia explicitly recommend against the systematic use of appetite stimulants, including mirtazapine, when used solely for appetite stimulation 1. While mirtazapine has been associated with weight gain as a side effect, the evidence supporting its use specifically for appetite stimulation is very limited:

  • Studies examining appetite stimulants have been conducted with weak methodology
  • Short-term benefits are inconsistent and uncertain
  • Potential harmful side effects must be weighed against uncertain benefits 1

Appropriate Clinical Contexts for Mirtazapine

Mirtazapine may be appropriate in specific clinical scenarios where appetite stimulation is a secondary benefit:

  1. Depression with comorbid appetite loss: When a patient has depression AND appetite/weight loss, mirtazapine can be considered as the antidepressant of choice 1
  2. Palliative care settings: In end-stage cardiovascular disease, mirtazapine may be useful for anorexia, particularly when patients also have sleep difficulties or mood disorders 1

Risks of Short-Term Use

Prescribing mirtazapine for just one week raises several concerns:

  • Discontinuation syndrome: Even at low doses, abrupt discontinuation after short-term use can cause anxiousness, nausea, tremor, and paradoxically, loss of appetite 2
  • Common side effects: Somnolence (54% of patients), increased appetite, weight gain, and dizziness 3, 4
  • Serious adverse effects: QT prolongation, angle-closure glaucoma risk, and potential for drug interactions 3

Limited Evidence for Inpatient Short-Term Use

Recent research examining appetite stimulants in hospitalized patients found:

  • No significant difference between appetite stimulants (including mirtazapine) in meal intake or weight change 5
  • While some numerical improvements in meal intake were observed, the evidence lacks standardization and generalizability 6
  • Higher quality evidence is needed before conclusions can be drawn about efficacy in short-term settings 6

Alternative Approaches

Instead of medication for appetite stimulation, consider:

  1. Addressing underlying causes of poor appetite
  2. Nutritional support strategies such as:
    • More frequent, smaller meals
    • Energy-dense meals
    • Supervision during meals
    • Emotional support during eating 1

Conclusion

The short-term use of mirtazapine solely for appetite stimulation for one week is not recommended based on current guidelines. The potential risks, including discontinuation syndrome and sedative effects, outweigh the uncertain benefits when used for such a short duration. If appetite stimulation is needed, consider addressing underlying causes and implementing non-pharmacological nutritional support strategies first.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Hunger for Mirtazapine: A Discontinuation Syndrome.

Journal of pain & palliative care pharmacotherapy, 2021

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Research

A review of the efficacy of appetite stimulating medications in hospitalized adults.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.